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Monopolar spindle 1 (Mps1) is a conserved apical ki-
nase in the spindle assembly checkpoint (SAC) that
ensuresaccuratesegregationofchromosomesduring
mitosis. Mps1 undergoes extensive auto- and trans-
phosphorylation, but the regulatory and functional
consequences of these modifications remain unclear.
Recent findings highlight the importance of intermo-
lecular interactions between the N-terminal extension
(NTE) of Mps1 and the Hec1 subunit of the NDC80
complex, which control Mps1 localization at kineto-
chores and activation of the SAC. Whether the NTE
regulates other mitotic functions of Mps1 remains un-
known. Here, we report that phosphorylation within
the NTE contributes to Mps1 activation through relief
of catalytic autoinhibition that is mediated by the
NTE itself. Moreover, we find that this regulatory NTE
function is independent of its role inMps1 kinetochore
recruitment. We demonstrate that the NTE autoinhibi-
tory mechanism impinges most strongly on Mps1-
dependentSACfunctionsandpropose thatMps1acti-
vation likely occurs sequentially through dimerization
of a ‘‘prone-to-autophosphorylate’’ Mps1 conformer
followed by autophosphorylation of the NTE prior to
maximal kinase activation segment trans-autophos-
phorylation. Our observations underline the impor-
tance of autoregulated Mps1 activity in generation
and maintenance of a robust SAC in human cells.
INTRODUCTION
Cell division is orchestrated by a precise and highly regulated
series of events. To avoid errors in chromosome segregation872 Current Biology 28, 872–883, March 19, 2018 ª 2018 The Autho
This is an open access article under the CC BY license (http://creativeduring mitosis and meiosis, the cell has evolved a signaling
mechanism called the spindle assembly checkpoint (SAC)
[1–3]. The SAC monitors the robustness of spindle microtubule
attachments during mitosis and delays the onset of anaphase
until all sister chromatids become appropriately attached.
SAC activity initiates at kinetochores, complex protein struc-
tures that form at centromeres and mediate the interaction
between dividing sister chromatids and spindle microtubules
during mitosis [2, 3]. Microtubule capture is thought to occur
at the outer kinetochore by the KMN network (KNL1 complex,
NDC80 complex, and MIS12 complex) [4], and some compo-
nents of this network, in particular Hec1 and Knl1, are directly
involved in SAC establishment. Knl1 is a major signaling hub
during mitosis, and its phosphorylation by Mps1, or alterna-
tively by Plk1, under conditions where Mps1 activity is compro-
mised or does not exist as in certain nematodes, initiates
SAC signaling. In contrast, dephosphorylation by a PP2A-PP1
relay is thought to be a major mechanism of attenuating the
SAC [5–7].
Mps1 has emerged as a master conductor of SAC signaling
and is one of the first protein kinases recruited to unattached
kinetochores in early mitosis [8]. Mps1 activity is regulated
by a cooperative series of auto- and transphosphorylation
reactions that appear to be dependent on Mps1 and Plk1
[6, 9–11]. Activated Mps1 phosphorylates the KNL complex
at conserved Thr residues in so-called MELT (for Met-Glu-
Leu-Thr core consensus) repeat motifs. This generates high-af-
finity binding sites for Bub3 and promotes recruitment of a
Bub1-Bub3-BubR1-Bub3 heterotetrameric complex to kineto-
chores [12–19]. Recent reports suggest that phosphorylation
of Bub1 by Mps1 promotes its binding to the Mad1-Mad2 het-
erodimer [20–22]. Mad1-Mad2 complex formation and activa-
tion occurs through a templating mechanism and involves
the conversion of an ‘‘open’’ O-Mad2 to a SAC-competent,
‘‘closed’’ C-Mad2 conformation [23]. Mps1 activity is required
for retaining both the Mad1-C-Mad2 complex and O-Mad2 atr(s). Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
unattached kinetochores during mitosis [24]. In line with these
pleotropic functions, depletion of Mps1 [25, 26] or chemical in-
hibition of its catalytic activity [9, 27, 28] confirmed a require-
ment for Mps1 in proper chromosome alignment and accurate
chromosome segregation.
Critical to human Mps1 activity is its localization to the kineto-
chore, which in human cells is primarily mediated by the non-cat-
alytic NTE (N-terminal extension), with a minor contribution from
the MR (middle region). Together, these regions sandwich a TPR
(tetratricopeptide repeat) motif, which also plays a role in Mps1
localization [29–34]. The NTE is a region of about fifty amino
acids at the extreme N terminus; it is rather poorly conserved
and lacks clear structural and functional domains. Recent evi-
dence suggests that human Mps1 localization is primarily
controlled by the NTE through competition with microtubules
for their binding site on the calponin homology (CH) domain of
Hec1 [35], although budding yeast Mps1 can also directly asso-
ciate with attached kinetochores [36]. The Mps1 MR contributes
to Mps1 localization through interactions with the CH domain of
Nuf2 that appear to be regulated by Aurora B phosphorylation
[32, 35, 37]. Despite poor conservation, the N terminus of fission
yeast Mph1 is also required for its kinetochore recruitment to
the NDC80 complex, albeit by potentially different mechanisms
[38, 39]. Curiously, in budding yeast, the NTE has been reported
to contribute toMps1 kinase activity [40]. Our previous studies of
humanMps1 also confirm that the N terminus of Mps1 promotes
catalytic activation [30], although whether this functionality is
associated with the NTE or the TPR remains unclear [29–31].
Taken together, these observations raise the intriguing possibil-
ity that the NTE of humanMps1may be involved in the regulation
of Mps1 kinase activity, in addition to a well-established role in
kinetochore docking.
In this study, we found that the NTE contributes to Mps1
catalytic activation that is independent of its role in kineto-
chore docking. We show that residues 40–49 in the NTE are
required for full kinase activation independent of Hec1 binding.
In particular, phosphorylation of this region promotes relief
of NTE-specific autoinhibition, which is required for optimal
SAC activity. An Mps1 mutant protein lacking residues 40–49
and mutated at adjacent phosphorylation sites fully restores
kinase and SAC function, suggesting that multiple phosphory-
lation events in the Mps1 NTE are required for complete acti-
vation of Mps1. Together, our data confirm that the Mps1 NTE
contributes to robust activation of the SAC through relief of
autoinhibition, in addition to its established role in kinetochore
binding.
RESULTS
Mps1-DNTE Exhibits Both Attenuated Activity and
Kinetochore Localization
To evaluate the potential role of the NTE in Mps1 localization and
catalytic activity, we generated an Mps1 construct lacking the
first 49 amino acids (Mps1-DNTE; Figure 1A). In agreement
with previous studies [31], MYC-Mps1-DNTE localized weakly
at kinetochores after depletion of endogenous Mps1 (Figure S1),
even after inhibition of Mps1 activity with reversine, which de-
creases Mps1 turnover at kinetochores [41] (Figure 1B). This ex-
tends previous reports and establishes that the effect of Mps1activity on localization is negligible in the absence of the NTE.
As a measure of Mps1 activation, we used phosphospecific an-
tibodies recognizing Mps1 activation loop pT676 and pT686
[6, 11]. In cells depleted of endogenous Mps1, MYC-Mps1
wild-type (WT) exhibited robust phosphorylation at the activation
loop (T676) and P+1 loop (T686) sites (together referred to as
the activation segment), whereas both MYC-Mps1 kinase-
dead (KD) (D664A) and MYC-Mps1-DNTE exhibited much lower
levels of phosphorylation (Figure 1C). Phosphorylation of a pro-
line-directed site (S821) was only marginally decreased in
MYC-Mps1-DNTE. Mps1-DNTE also exhibited attenuated gel
retardation when compared with Mps1-WT, characteristic of
reduced activity-dependent autophosphorylation (Figure S2).
Finally, we measured in vitro catalytic output using both Mps1
autophosphorylation and phosphorylation of MBP (myelin basic
protein) (Figures 1D and 1E). As expected, Mps1-WT was effi-
cient at both auto- and substrate phosphorylation, whereas
Mps1-KD was completely ineffective at both. Surprisingly, and
in contrast to observations with the phosphospecific antibodies
in cell extracts, the isolated Mps1-DNTE phosphorylated both
itself and MBP as efficiently as Mps1-WT.
Mps1 Clustering by the NTE Supports Mps1 Kinase
Activity
One possible interpretation of the discordance between the re-
sults obtained with phosphospecific antibodies and in vitro ki-
nase assays is that a high degree of antibody-mediated Mps1
clustering induced by immunoprecipitation prior to the in vitro ki-
nase assay may serve to promote Mps1 autoactivation in trans
[9, 10, 26, 42, 43]. A cellular function of Mps1 kinetochore local-
ization might therefore be increasing the local concentration of
Mps1 to trigger autoactivation [42]. To test this idea, we ex-
pressed Lac repressor (LACI) fusion proteins with Mps1 in
U2OS cell lines expressing 256 copies of the Lac operator in
chromosome 1 [44]. In nocodazole-arrested cells, MYC-LACI-
Mps1-WT (but not Mps1-KD) was phosphorylated at T686, as
expected. In contrast, MYC-DNTE was very poorly phosphory-
lated at this site, whereas MYC-LACI-Mps1-DNTE was able to
autophosphorylate efficiently (Figure 2A). These results were
confirmed using quantitative immunofluorescence (Figures 2B
and 2C). In agreement, forced kinetochore localization of
Mps1-DNTE via N-terminal fusion to the kinetochore component
Mis12 (Figure S3A) restoredMps1-DNTE autophosphorylation at
both T686 and T676 to levels comparable to Mps1-WT (Fig-
ure 2D). To test the idea that dimerization of Mps1-DNTE may
promote its activity regardless of subcellular localization, we ex-
ploited chemical-induced dimerization. To accomplish this, we
generated Mps1 proteins fused to the FK506-binding protein
(FKBP), which homodimerizes in the presence of the small-mole-
cule ligand, AP20187. In nocodazole-arrested cells treated
with AP20187, MYC-Mps1-DNTE was poorly phosphorylated,
whereas AP20187 treatment resulted in a rescue of autophos-
phorylation at T686 in MYC-FKBP-Mps1-DNTE-expressing cells
to levels similar to those observed with Mps1-WT. As expected,
MYC-FKBP-Mps1-KD was not autophosphorylated at T686
(Figure 2E). Thus, enforcedMps1-DNTE dimerization in the cyto-
plasm during mitosis is sufficient to induce its activation, con-
firming the importance of Mps1 clustering for activation through
promotion of autophosphorylation.Current Biology 28, 872–883, March 19, 2018 873
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Figure 1. Mps1-DNTE Exhibits Attenuated
Activity and Kinetochore Localization
(A) Mps1 domains and phosphorylation sites rele-
vant to this study.
(B) Mitotic cells expressing Myc-GFP-Mps1 WT
and DNTE and siMps1 were treated and immuno-
stained as indicated. The scale bar represents
5 mm. Quantification shows the MYC-Mps1/Hec1
ratio. ****p < 0.0001.
(C) Phosphorylation of MYC-Mps1-WT, -KD, or
-DNTE expressed in mitotic HEK293T cells
together with Mps1 small interfering RNA (siRNA).
(D) In vitro kinase assay of MYC-GFP-Mps1-WT,
-KD, and -DNTE expressed as in (C) and visualized
by autoradiography (first and third panels). Coo-
massie Blue shows equal loading.
(E) Quantification of Mps1 autophosphorylation
from (D).
Data are means ± SEM from n = 2 independent ex-
periments. ***p < 0.001. See also Figures S1 and S2.To provide functional evidence for this mechanism, we verified
the effect of clustering endogenous Mps1 at kinetochores by
measuring phosphorylation of the physiological Mps1 substrate
Knl1 with pT875 phosphospecific antibodies (hereafter referred
to as pMELT) [13, 14, 16–19]. Treatment with Taxol and noco-
dazole has been proposed to differentially affect Mps1 recruit-
ment levels; Taxol-hyperstabilized microtubules are thought
to compete with (and therefore decrease) Mps1 localization at
kinetochores,whereasnocodazoledestabilizesmicrotubule inter-
actions associated with increased recruitment of Mps1 to kineto-
chores [35]. We confirmed these observations (Figure S3E) and
demonstrated that, in both HeLa S3 (Figures 2F and S3D) and
RPE-1 (FiguresS3BandS3C) cells, pMELT:Mps1 signals at kinet-
ochores were significantly lower in Taxol-arrested cells when
compared to nocodazole-arrested cells. Collectively, these data
imply that there is a negative correlation between Mps1 kineto-
chore occupancy and substrate phosphorylation and that NTE-
mediated kinetochore localization contributes toMps1 activation.874 Current Biology 28, 872–883, March 19, 2018Dissection of the NTE Reveals an
Autoinhibitory Motif Regulating
Kinase Activity
Our data thus far suggest that the
Mps1 NTE promotes high local concen-
trations of the kinase at kinetochores,
which contributes to its own optimal acti-
vation. We next sought to determine the
specific region of the NTE that drives
this process. Although the NTE is rather
poorly conserved, N-terminal alignment
of multicellular eukaryote sequences re-
vealed three short regions of conservation
within the first 49 amino acids that we
reasoned might be important for NTE
functions (Figure 3A). We therefore gener-
ated a panel of different Mps1 mutants:
the deletion mutants Mps1-D7, Mps1-
D19–29, and Mps1-D40–49, as well as
Mps1-5A, which consists of alaninemuta-tions of a conserved acidic region (30-31-33-34-35), including
the previously identified autophosphorylation site T33 [45].
Using phosphospecific Mps1 antibodies, we tested phos-
phorylation of these mutants together with Mps1-DTPR. As ex-
pected, Mps1-WT, but not Mps1-KD, was phosphorylated at
both T686 and T676, whereas Mps1-DNTE displayed mark-
edly decreased autophosphorylation as described above.
Mps1-D7, Mps1-D19–29, and Mps1-5A displayed only very
slightly reduced levels of Mps1 autophosphorylation compared
to Mps1-WT. In contrast, Mps1-D40–49 and Mps1-DTPR ex-
hibited decreased phosphorylation profiles that were similar
to Mps1-DNTE (Figure 3B). Individual HeLa cells depleted of
endogenousMps1 and expressingMps1-D40–49 also displayed
a significantly attenuated pT686 signal compared to cells
rescued with Mps1-WT (Figure 3C). This suggests that, whereas
multiple regions of the NTE may incrementally contribute to
Mps1 activity, residues 40–49 in the NTE play a more significant
role in Mps1 catalytic autoactivation.
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Figure 2. Mps1 Clustering in the NTE Supports Its Kinase Activity
(A) Immunoblotting with the indicated antibodies of MYC-LacI-Mps1-WT, -KD, -DNTE, or MYC-Mps1-DNTE expressed with siMps1 in a U2OS line expressing
a LACO array and enriched in mitosis.
(B) Cells were treated as in (A) but fixed for immunofluorescence as indicated. The scale bar represents 5 mm.
(C) Quantification of pT686/MYC-Mps1 ratios from (B). *p < 0.05; n = 3.
(D) Immunoblotting was performed with the antibodies shown on lysates from cells expressing the indicated Mps1 constructs.
(E) Cells were transfected with the indicated MYC-FKBP-Mps1 constructs together with siMps1, synchronized in mitosis, and treated with 10 nM AP20187 1 hr
before immunoblotting as indicated. Note that an intermittent band has been excised out.
(F) HeLa cells were treated overnight with the indicated drugs before fixation. Quantification of pMELT/Mps1 ratios is shown. **p < 0.01.
See also Figure S3.Our data reveal that Mps1 clustering at the kinetochore via the
NTE promotes its activation, and so we next sought to determine
the subcellular localization of Mps1-D40–49, reasoning that
these residues might contribute to Hec1 binding, which is
required for optimal kinetochore association. We examined the
localization of the Mps1 mutants while concomitantly depleting
endogenous Mps1 to prevent dimerization with the endogenous
protein. Surprisingly, Mps1-D40–49 behaved like Mps1-WT,
whereas Mps1-DNTE localized very weakly to kinetochores in
the absence or presence of reversine (Figures 3D and 3E), as
previously established (Figure 1B). In agreement with these
observations, Mps1-DNTE associated more weakly with recom-
binant GST-CHHEC1 in pull-down experiments, whereas Mps1-
WT and Mps1-D40–49 were bound to GST-CHHEC1 at similar
levels (Figure 3F). Collectively, our data suggest that, whereasMps1 kinetochore docking helps to promote catalytic activity,
the enzymatic and localization functions of the Mps1-NTE can
be uncoupled.
Residues 40–49 Form an NTE-Specific Kinase
Autoinhibitory Module
Considering that immunoprecipitation and clustering of Mps1-
DNTE restored catalytic activity, we reasoned that NTE residues
40–49 might be involved in Mps1 dimerization and catalytic acti-
vation. Similar reasoning also led us to hypothesize that clus-
tering by immunoprecipitation of the Mps1-DTPR deletion
mutant, which localizes less efficiently than Mps1-WT to kineto-
chores [31], might restore activity. Consistently, Mps1-DNTE
and Mps1-DTPR demonstrated levels of activity equivalent to
Mps1-WT when immunoprecipitated and subjected to in vitroCurrent Biology 28, 872–883, March 19, 2018 875
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Figure 3. Dissection of the NTE Reveals an Autoinhibitory Motif Regulating Kinase Activity
(A) Evolutionary conservation of the Mps1 NTE and deletion mutants generated for this study. Residues targeted are indicated with an asterisk.
(B) HEK293T cells were transfected with the indicated plasmids together with siMps1 before enrichment in mitosis and immunoblotting with the indicated
antibodies.
(C) Cells expressing indicated Mps1 constructs and siMps1 were synchronized in mitosis before fixation and immunostaining as shown. Quantification of pT686/
CREST ratios is shown. ****p < 0.0001.
(D) HeLa cells expressing the indicated constructs, together with siMps1, were fixed and immunostained as indicated. The scale bar represents 5 mm.
(E) Quantification of the MYC-Mps1/CREST ratio from (D); *p < 0.05; ***p < 0.001.
(F) Pull-down of indicated MYC-GFP-tagged Mps1 with GST-CHHEC1.
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Figure 4. Residues 40–49 Form anNTE-Spe-
cific Kinase Autoinhibitory Module
(A) In vitro kinase assay of MYC-GFP-Mps1 con-
structs. Coomassie blue staining indicated equal
loading. Quantification of Mps1 autophosphor-
ylation is shown; data are means ± SEM; n = 3.
*p < 0.05 and **p < 0.01.
(B) Immunoblotting with the indicated antibodies of
the various MYC-Mps1 mutant proteins.
(C) MYC immunoprecipitates from cells ex-
pressing the indicated MYC-Mps1 constructs
were resolved by SDS-PAGE and immunoblotted
as shown.
(D) Cells were treated as in (C), enriched in mitosis
with nocodazole, and immunoblotted as indicated.
See also Figures S4 and S5.kinase assays (Figure 4A). Interestingly, immunoprecipitated,
clustered Mps1-D40–49 still exhibited reduced activity, whereas
that of a distinct deletion mutant (Mps1-D19–29) was compara-
ble toMps1-WT, suggesting that amino acids 40–49 are required
for Mps1 activation. The observation that clustering restores full
kinase activity to Mps1-DNTE and Mps1-DTPR, but not Mps1-
D40–49, strongly suggests that residues 40–49 are required
to modulate Mps1 autoinhibition by the NTE itself. To test
this idea directly, we generated double mutants of the NTE,
combining the 40–49 deletion with other NTE mutants, namely
D19–29, D7, and 5A, and assessed autophosphorylation in cell
extracts. The Mps1 D40–49/5A double mutant exhibited auto-
phosphorylation to levels comparable with that of Mps1-WT
(Figure 4B). The activity of two other double mutants, Mps1-
D40–49/D7 and Mps1-D40–49/D19–29, remained unchanged
compared to Mps1-D40–49.
The 40–49 region harbors several potential phosphorylation
sites, including residues T45, T46, and the bona fide autophos-
phorylation site S49 (Figure 3A) [46], raising the possibility that
autoinhibition may be a result of the loss of phosphorylation in
this region. Collective mutation of all three sites to alanine
(Mps1-3A) resulted in a marked decrease of Mps1 phosphoryla-
tion at T686, which was rescued by a triple phosphomimetic
Mps1-3E mutant (Figure 4C, top 3 panels). These data suggestCurrenthat phosphorylation of a short auto-
inhibitory motif in the NTE is required
for full activation of Mps1, likely through
release of an NTE-specific autoinhibitory
segment.
The unexpected finding that phosphor-
ylation in the Mps1 NTE is required for
efficient Mps1 autophosphorylation and
catalytic activation suggested that NTE
phosphorylation might occur prior to
maximal activation segment phosphory-
lation. To evaluate this idea more closely,
we sought to determine the phosphor-
ylation of the NTE in the hypoactive
Mps1-D40–49 mutant. We generated a
phosphospecific antibody against T33
(Figure S4), anMps1 autophosphorylation
site [45, 47, 48], and one of the residuesimplicated in driving relief of autoinhibition by the NTE. We found
that Mps1-3A and Mps1-3E exhibited T33 phosphorylation that
was equivalent to Mps1-WT, whereas neither Mps1-DNTE nor
Mps1-KD was phosphorylated (Figure 4C, bottom panel), con-
firming that T33 is indeed an Mps1 autophosphorylation site.
Consistently, Mps1-D40–49 and Mps1-WT exhibited compara-
ble phosphorylation at T33 despite a decrease in T686 and
T676 phosphorylation compared to Mps1-WT (Figure 4D). Phos-
phorylation of all mutants at S821 was comparable between
Mps1 proteins (Figures 4C and 4D). These observations demon-
strate that NTE T33 phosphorylation, in contrast to activation
segment phosphorylation, is insensitive to theNTE autoinhibitory
‘‘module’’.
We next sought to better understand the initial steps involved
in Mps1 activation. Co-transfection of differentially tagged Mps1
WT and KD resulted in phosphorylation of the KD mutant at both
T686 and T33, indicating that NTE phosphorylation occurs in
trans (Figure S5A). In addition, we tested NTE phosphorylation
by Plk1, which shares a similar substrate consensus as Mps1
and has been implicated in Mps1 activation [6, 7]. We estab-
lished that the NTE is a poor substrate for Plk1, at least in vitro,
whereas it was efficiently phosphorylated by Mps1 (Figures
S5B–S5E); residual phosphorylation is likely due to other target
Mps1 sites in the NTE, TPR, or both. Finally, Plk1 inhibitiont Biology 28, 872–883, March 19, 2018 877
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Figure 5. The Mps1 NTE Interacts Directly
with the Kinase Domain
(A) A bacterially expressed, 63HIS-tagged N-ter-
minal fragment of Mps1 (residues 1–301) was
subjected to limited proteolysis, resolved by SDS-
PAGE, and identified by mass spectrometry; n = 2.
(B) Mps1N- andC-terminal fragments weremixed,
immunoprecipitated with an antibody specific for
Mps1’s C terminus, resolved by SDS-PAGE, and
detected using an anti-His HRP-conjugated anti-
body; n > 3.
(C) Mps1-C (510–809) alone or mixed with Mps1-N
(1–225) was subjected to velocity sedimentation
on a 5%–20% glycerol gradient. Fractions were
resolved by SDS-PAGE and detected as in (B).
Sedimentation peaks of conalbumin and oval-
bumin are shown; n = 2.
(D) Elution profile of Mps1-C and Mps1-C +
Mps1-N on a Superdex 200 size-exclusion col-
umn. Elution peaks of ovalbumin and chymo-
trypsin are indicated; n = 2.
(E) Mps1-WT and Mps1-KD cross-linkage map.
Black, linkages in both Mps1-WT and Mps1-KD;
green, Mps1-WT linkages; red, Mps1-KD linkages.
(F) Mps1-WT-specific linkages; NTE-kinase links
are marked in green.
See also Tables S1 and S2.resulted in a consistent decrease of Mps1 T686 phosphorylation
in both Mps1-WT- and Mps1-D40–49-expressing cells, indi-
cating that Plk1 contributes to Mps1 activation independently
of the NTE (Figure S5F).
TheMps1NTE InteractsDirectlywith theKinaseDomain
Intermolecular NTE phosphorylation by Mps1 requires a topol-
ogy in which sites proximal to the NTE interact with the active
Mps1 in order to promote phosphorylation. We evaluated such
a mechanism in vitro by employing stable, 63His-tagged re-
combinant Mps1 fragments that were isolated after limited
proteolysis (Figure 5A). Mps1 N-terminal fragments (residues
1–301, 1–225, and 27–225) were incubated with recombinant
63His-tagged C-terminal Mps1 fragments (residues 302–859
and 510–809) and then immunoprecipitated with an Mps1 C ter-
minus antibody. All N-terminal Mps1 fragments interacted
directly with both C-terminal fragments of Mps1 (Figure 5B).
Next, we used velocity sedimentation to determine complex
formation between N- and C-terminal Mps1 fragments (Fig-
ure 5C). After co-incubation with Mps1-N(1–225), Mps1-
C(510–809) displayed a shifted sedimentation profile, indicating
efficient complex formation. Finally, we tested association be-878 Current Biology 28, 872–883, March 19, 2018tween Mps1-N(1–225) and Mps1-C(510–
809) fragments by analytical size-exclu-
sion chromatography, which confirmed
direct complex formation between the
N and C termini of Mps1 (Figure 5D).
To fine-map intramolecular Mps1 inter-
actions, and further explore the depen-
dence of these interactions on Mps1
activity, we employed chemical cross-
linking and mass spectrometry [49].Glutathione S-transferase (GST)-Mps1-WT and KD purified to
homogeneity from insect cells were individually cross-linked
with bis(sulfosuccinimidyl)suberate (BS3) prior to peptide identi-
fication by mass spectrometry (Figures 5E and 5F; see also
Tables S1 and S2). Importantly, we established that the chemical
cross-linking map of Mps1-WT and Mps1-KD varied greatly
with only a small number of shared cross-links and with Mps1-
WT forming a far greater number of unique cross-links than
Mps1-KD (Figure 5E). This suggests the existence of significant
conformational differences between catalytically active (and
highly phosphorylated) and inactive full-length Mps1 polypep-
tides [50]. Interestingly, interactions formed between the NTE
and kinase domain of Mps1 were only identified in Mps1-WT
and not Mps1-KD cross-links, suggesting that Mps1 autophos-
phorylation and activation is coincident with direct interactions
between its N and C termini.
Mps1 NTE-Mediated Relief of Autoinhibition Is Required
for SAC Activity, but Not Chromosome Segregation
Fidelity
To explore the cellular consequences of NTE-mediated Mps1
autoinhibition on critical mitotic functions of Mps1, we generated
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Figure 6. Relief of NTE-Mediated Autoinhi-
bition Is Required for Activity
(A and B) Stable HeLa T-rex lines expressingMYC-
GFP-Mps1-WT and mutants were treated with
siMps1, synchronized in mitosis, fixed, and
immunostained as indicated. The scale bar repre-
sents 5 mm. Quantification of pMELT (A) and Mad2
(B) intensities is shown. *p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001.
(C and D) Cells were treated as in (A) but fixed
after overnight nocodazole treatment and stained
with the indicated antibodies. The mitotic index
is shown; n = 3. Cells countedR100 per cell lines
per experiment.
(E) Time-lapse microscopy of cells expressing
indicated constructs. Mitotic timing is quantified.
R50 expressing cells were counted for each
condition. n = 2. ***p < 0.001; ****p < 0.0001.
See also Figure S6 and Movies S1, S2, S3, and S4.a panel of HeLa T-Rex stable cell lines expressing Mps1 NTE
mutants (Figures S6A–S6D) and tested the effect of various
NTE deletions and mutations on SAC dynamics, mitotic timing,
and chromosome congression in cells simultaneously depleted
of endogenous Mps1. As a first test for SAC signaling, we exam-
ined MELT motif phosphorylation. Mps1-WT-expressing cells
demonstrated robust pMELT signals, whereas Mps1-D40–49-
and DNTE-expressing cells exhibited a significant decrease in
MELT motif phosphorylation, indicative of attenuated SAC sig-
nals (Figure 6A). MELT phosphorylation initiates the signaling
cascade that ultimately results in the accumulation of MAD2 atCurrenkinetochores. We therefore determined
the levels of O-MAD2 recruited to kinet-
ochores, confirming that expression
of Mps1-D40–49 significantly reduced
O-MAD2 recruitment (Figure 6B) [51].
Finally, we measured mitotic arrest in
the presence of nocodazole and found
that Mps1-D40–49-expressing cells ex-
hibited a significantly lower mitotic index
when compared to Mps1-WT (Figure 6C).
Importantly, in a cell line expressing
Mps1-D40–49/5A, in which Mps1 activa-
tion loop phosphorylation was recovered
(Figure 4B), the SAC arrest defect was
also rescued (Figures 6D, S6C, and
S6D). We next used live-cell imaging to
determine the duration of mitosis (defined
by the time interval between nuclear en-
velope breakdown and anaphase onset)
in our stable cell lines. Mitotic timing
wasmarkedly decreased from an average
of 40.8 ± 2.09 min for siGL2-treated cells
to 26.32 ± 0.94 min (p < 0.0001 one-
way ANOVA) in Mps1-depleted cells in
agreement with previous literature
(Figure S6E) [25, 26, 37, 52]. MYC-
GFP Mps1 WT rescued mitotic timing
(43.78 ± 3.25 min), whereas Mps1-KDand Mps1-DNTE did not, with an average duration of 22.51 ±
0.97 min and 30.40 ± 1.25 min, respectively (p < 0.0001;
ANOVA; Figure 6E). Although Mps1-D40–49-expressing cells
completed mitosis at a significantly faster rate than Mps1-WT-
expressing cells, this effect was not as pronounced as that
observed with the other NTE mutants (34.21 ± 1.46 min;
p < 0.001; ANOVA; see Movies S1, S2, S3, and S4). Thus, the
40–49 NTE motif is required for full SAC function in addition to
efficient mitotic timing.
Alongside SAC signaling, Mps1 kinase activity also regu-
lates kinetochore-microtubule interactions [9, 25–28, 46]. Tot Biology 28, 872–883, March 19, 2018 879
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Figure 7. Differential Dephosphorylation Kinetics of Mps1 Substrates after Chemical Inhibition
(A) Stable HeLa T-rex lines expressingMYC-GFP-Mps1-WT ormutants were treatedwith siMps1 and synchronized inmitosis before fixation and immunostaining
as shown. Lagging chromosomes in anaphase cells were determined by CREST staining. n = 3, andR30 anaphases were counted for each condition.
(B) Cells were treated as in (A) with the addition of nocodazole (7.5 ng/mL).
(C) Cells were treated with the indicated doses of reversine for 5 min before fixation and immunofluorescence as indicated.
(D) Model of NTE phosphorylation and Mps1 activation.
See also Figure S7.examine the role of the NTE-mediated partial autoinhibition in
this process, we evaluated the extent of lagging chromosomes
in anaphase (Figure 7A). This phenotype was most pro-
nounced in cells expressing Mps1-KD, with approximately
60% of the cells displaying lagging chromosomes. Cells ex-
pressing Mps1-DNTE displayed lagging chromosomes in
approximately 43% of cells, respectively (p < 0.001; 2-way
ANOVA), whereas Mps1-D40–49-expressing cells showed no
apparent increase in lagging chromosomes when compared
to Mps1-WT (p > 0.9999; 2-way ANOVA), even in the presence
of low doses of nocodazole to induce spindle stress (Fig-
ure 7B). To understand why Mps1 D40–49 only attenuated
the SAC functions of Mps1, we examined the effect of Mps1
partial inhibition on specific Mps1 substrates involved in sup-
porting the SAC (pMELT) and chromosome congression (SKA3
pS34) [46]. In response to increasing doses of reversine, MELT
motif phosphorylation was significantly more sensitive to Mps1
inhibition than SKA pS34 (Figure 7C). This is in agreement with
very recent observations demonstrating a preference for pThr
over pSer residues by PP2A upon mitotic exit [53] and poten-
tially explains why the partial inhibition of Mps1-D40–49 im-
pinges more strongly on the SAC rather than chromosome
segregation.880 Current Biology 28, 872–883, March 19, 2018DISCUSSION
Mps1 lies at, or near, the apex of the SAC-signaling cascade,
and its localization at kinetochores serves an important role in
increasing the local concentrations of Mps1 at its site of action,
which in turn promotes Mps1 catalytic activity (Figure 2). We
confirm that the Mps1 N-terminal region contributes to the
SAC by mediating kinetochore docking of Mps1 (Figures 1A
and 1B) [29, 31, 32, 35]. Moreover, the NTE also contributes to
the SAC via an additional localization-independent mechanism:
autoinhibition of Mps1 kinase activity. Autoinhibition is a com-
mon safety feature built into kinase regulation that prevents
premature autophosphorylation until triggered by an external
stimulus [54]. In the case of Mps1, we suggest that auto-
inhibition might be necessary to ensure no basal SAC signaling
in the absence of improper microtubule attachments of sister
chromatids.
In this study, we demonstrate that the NTE participates in
Mps1 autoinhibition, leading to attenuation of activation loop
phosphorylation. We further establish that autophosphorylation
in the NTE is important to release this autoinhibition, which
subsequently permits activation of Mps1 through maximal
phosphorylation in the activation segment. In its partially
autoinhibited form, residual Mps1 activity does not support a
full SAC response but appears to be sufficient to promote
productive microtubule attachments, possibly as a result of
the differential sensitivity of substrates to local dephosphoryla-
tion (Figure 7C). Our data are thus consistent with a model
where Mps1 activation is a complex, multistep process that
requires initial dimerization, leading to allosteric stabilization
of a partially active, ‘‘prone-to-autophosphorylate’’ transient
Mps1 conformer prior to trans-autophosphorylation at multiple
sites in the Mps1 NTE residing between residues 30 and 50
[55]. This mechanistic switch then releases a partial NTE-spe-
cific autoinhibition, enabling activation segment phosphoryla-
tion at T676 and T686 (Figure 7D), which are known to be
associated with kinase activation [10, 11, 56, 57]. An attractive
model is that NTE phosphorylation and association with the
kinase domain may result in a disorder-to-order conformational
transition in this region, allowing the release of autoinhibition
and promotion of catalytic autoactivation. Importantly, the ef-
fect of autoinhibition only occurs in the context of the full-length
Mps1 molecule. In the absence of the NTE or the TPR, the
decrease in kinase activity is a result of the loss of efficient
Mps1 kinetochore docking and clustering (Figures 2 and 3B)
[29–31]. Considering that T33 is one of the residues whose
mutation rescues kinase activity in the Mps1-D40–49 mutant,
its mechanism of phosphorylation is insensitive to the partial
autoinhibition imposed by the NTE (Figure 4). To the best of
our knowledge, this is the first example of a graded response
to catalytic autoinhibition between individual autophosphoryla-
tion sites in Mps1 or any other mitotic kinase.
How might NTE phosphorylation relieve catalytic auto-
inhibition? Our in vitro binding and cross-linking experiments
revealed unique interactions between the NTE of Mps1 and
its kinase domain that are absent in Mps1-KD, which lacks
autophosphorylation [50]. This is in agreement with the idea
that NTE phosphorylation is Mps1-dependent and strongly
supports our model that NTE phosphorylation is required for
efficient Mps1 activation at levels that fully support mitotic
functions. Mapping the kinase domain residues identified in
the cross-links with the NTE onto the Mps1 kinase structure
suggests that the NTE region interacts with the N-terminal
lobe at the residues V539FQVLNEKK547 and Q579QHSDKIIR587.
Our crystal structure of the Mps1 catalytic domain in an in-
hibited conformation [56] shows that residues in the
Q579QHSDKIIR587 region form part of the aC helix, a structural
feature critical to kinase activity, and are in close spatial
proximity (5 A˚ or less) to the activation segment and catalytic
loops (Figure S7). We thus anticipate that the Mps1 NTE and
kinase domain interact to trigger long-range conformational
changes that fine-tune phosphorylation of Mps1 substrates
and the maintenance of high kinase activity. Structural studies
of the full-length active and inactive Mps1 will be required to
further test our models and reveal the precise mechanism
through which NTE phosphorylation promotes activation
loop phosphorylation in Mps1. However, our study provides
a mechanistic framework for understanding how Mps1 cata-
lytic activity is autoinhibited, primed, and then generated
and advances our understanding of the fine-tuning mecha-
nisms by which Mps1 exerts control over the SAC in human
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Anti-Mps1 C terminus Santa Cruz Biotechnology Cat# sc-540, RRID:AB_632567
Anti-Mad2 Clone #107-276-3 Gift of Erich Nigg [50] N/A
Anti-a-tubulin (Clone DM1A) Santa-Cruz Biotechnology Cat# sc-32293, RRID:AB_628412
Anti-Cenp-C MBL International Cat# PD030, RRID:AB_10693556
Anti- polyHistidine-HRP peroxidase Sigma Cat# A7058
Anti-GFP Sigma-Aldrich (Roche) Cat# 11814460001, RRID:AB_390913
Ant-CREST Immunovision Cat# HTC-0100
Bacterial and Virus Strains
Escherichia coli: BL21(DE3) EMB Millipore Cat. No. #69450
Spodoptera frugiperda: SF9 ATCC CRL-1711, CLS Cat# 604328/p700_Sf9,
RRID:CVCL_0549
Chemicals, Peptides, and Recombinant Proteins
Nocodazole Sigma-Aldrich Cat# M1404-10MG
Taxol (Paclitaxel, Taxus sp) Calbiochem Cat# 580555
Reversine Sigma-Aldrich Cat# R3904-1MG
BI2536 Reagents Direct 88-Q71
Thymidine Acros Cat# 226740050
Hygromycin B Wisent (MultiCell) Cat# 450-141-XL
Tetracycline Sigma-Aldrich Cat# T7660-5G
Polyethylenimine Polysciences Cat# 23966
bis(sulfosuccinimidyl)suberate (BS3) Thermo Fisher Scientific Cat# 21580
Blaticidin S HCL GIBCO Cat# A11139-03
Mps1 T33 phosphopeptide: CKNEDL(pT)DELS Custom synthesis, EZBiolab N/A
Critical Commercial Assays
Pierce BCA Protein Assay Kit ThermoScientific Cat# 23225
Trans-IT transfection kit Mirus Bio Cat# MIR2305
JetPRIME Polyplus-transfection Cat# 114-07
Oligofectamine Invitrogen Cat# 12252-011
glutathione-agarose beads (Glutathione Sepharose
4B Media)
GE Healthcare Cat# 45-000-139
Experimental Models: Cell Lines
Human: HeLa S3 E.Nigg Lab ATCC Cat# CRL-7924, RRID:CVCL_0058
Human: HeLa T-REX A.Desai Lab N/A
Human: HEK293T E.Nigg Lab ATCC Cat# CRL-3216, RRID:CVCL_0063
Human: hTERT-RPE1 E.Nigg Lab ATCC Cat# CRL-4000
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Oligonucleotides
Mps1 DsiRNA Oligos A: 50-GUAGAUUUCCACA
GGGAUUCAAGAGUA- 30
DTI N/A
Mps1 DsiRNA Oligos B: 50-AUACAGUGCCAUA
AGUGGUUGCUAUUU-30
DTI N/A
GL2i (Luciferase Gl2 siRNA) sense: 50-UCG AAG
UAU UCC GCG UAC G(dT)(dT)- 30, anti-sense:
50-CGU ACG CGG AAU ACU UCG A(dT)(dT)-30
Life Technologies N/A
Recombinant DNA
pcDNA 3.1-3xmyc-(A)-Mps1 WT [29, 30] N/A
pcDNA 3.1-3xmyc-(A)-Mps1 KD [29,30] N/A
pcDNA 3.1-3xmyc-(A)-Mps1 DNTE This study N/A
pcDNA 3.1-3xmyc-(A)-Mps1 D7 This study N/A
pcDNA 3.1-3xmyc-(A)-Mps1 5A This study N/A
pcDNA 3.1-3xmyc-(C)-Mis12-Mps1 DNTE This study N/A
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 WT This study N/A
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 KD This study N/A
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 D40-49 This study N/A
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 D19/29 This study N/A
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 DNTE This study N/A
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 40-49/5A This study N/A
PGEX 6P3 GST-HEC1 CH domain This study N/A
pcDNA 3.1-3xmyc-A-Mps1 DTPR This study N/A
pcDNA 3.1-3xmyc-(A)-FKBP-Mps1 WT This study N/A
pcDNA 3.1-3xmyc-(A)-FKBP-Mps1 KD This study N/A
pcDNA 3.1-3xmyc-(C)-FKBP-Mps1 DNTE This study N/A
pcDNA 3.1-3xmyc-(A)-LacI -Mps1WT This study N/A
pcDNA 3.1-3xmyc-(A)-LacI -Mps1 KD This study N/A
pcDNA 3.1-3xmyc-(C)-LacI -Mps1 D49 This study N/A
pcDNA 3.1-3xmyc-(A)-Mps1 D19-29 This study N/A
pcDNA 3.1-3xmyc-(A)-Mps1 D40-49 This study N/A
pDest17-Mps1 (1-301) This study N/A
pDest17-Mps1 (1-225) This study N/A
pDest17-Mps1 (27-225) This study N/A
pDest17-Mps1 (302-856) This study N/A
pDest17-Mps1 (510-801) This study N/A
pDest20-Mps1-WT This study N/A
pDest20-Mps1-KD This study N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Sabine
Elowe (Sabine.Elowe@crchudequebec.ulaval.ca).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
Human HeLa-S3 (Female), HeLa T-Rex (Female) and HEK293T cells were grown at 37C with 5% CO2 in DMEM (Hyclone) supple-
mented with 10% fetal bovine serum or bovine growth serum (PAA) and pen/strep (100 mg/ml, Hyclone). U2OS cells expressing a
256-copy array of the Lac operator sequences were a kind gift of David Spector (CSHL) and were maintained in the presence of
100 mg/ml of hygromycin B. HeLa Flp-in T-Rex cell line was used for generation of stable isogenic cell lines, and was a generous
gift from Arshad Desai (Ludwig cancer research).Current Biology 28, 872–883.e1–e5, March 19, 2018 e2
Stable cell lines were generated using Flp-In system (Life Technologies). Transfection was done with TransIT-LT1 (Mirus Bio) re-
agent according to the manufacturer’s instructions. The transfection reagent was mixed with the pOG44 Flp-Recombinase Expres-
sion Vector and the pCDNA5/TO/FRT-Mps1 vector with a 1:1 ratio in OptiMEMmedia. Selection started 48h after the transfection in a
DMEMmedia supplemented with 10%of bovine growth serum (PAA), pen/strep (100 mg/ml, Hyclone) and in the presence of hygrom-
ycin B (200mg/ml, MultiCell) and blasticidin (10 mg/ml, GIBCO by Life Technologies). Media was replaced 3 times a week for 3 weeks
and then single colonies were picked and grown separately. Expression of the Mps1 construct was then tested by IF and WB after
24h of tetracycline treatment.
Drug treatments and transfections
Drug treatments were realized as follows: nocodazole (Sigma, as indicated, 16h), thymidine (Acros Organics, 2 mM for 16 h),
reversine (Sigma, 0.5 mM, 30min), taxol (Calbiochem, 0.2 mM, 16h). For experiments with stable cell lines, 24h before harvesting cells,
1mg/ml of tetracycline was added to express the protein of interest. Plasmid transfections were performedwith PEI (polyethylenimine)
at a 15:2 (PEI/DNA) ratio for HEK293T cells and with TransIT (Mirus Bio) for HeLa S3 cells according to the manufacturer’s instruc-
tions. Endogenous protein depletion was carried out with DsiRNAs (IDT), using Oligofectamine(Invitrogen) for HEK293T cells and
HeLa-S3 or JetPRIME (Polyplus-transfection) for stable cell line HeLa Flp-In Trex and analyzed at 48-72h after transfection.
The Mps1 and Hec1 DsiRNA targets the following sequence:
Mps1 A: 50-GUAGAUUUCCACAGGGAUUCAAGAGUA- 30
Mps1 B: 50-AUACAGUGCCAUAAGUGGUUGCUAUUU-30
Site-directed mutagenesis was performed using PCR and overlapping mutagenic primers. All constructs were verified by
sequencing.
METHOD DETAILS
Protein lysis and immunoprecipitation
Lysis of cell pellets for immunoblotting and immunoprecipitation was done with RIPA lysis buffer (150 mM Tris-HCl pH 7.5, 150 mM
NaCl, 10mMNaF, 1%NP-40, 0.1%Na-deoxycholate and a protease and phosphatase inhibitor cocktail that included 20mM b-glyc-
erophosphate, 0.1mMsodium vanadate, 10mMsodiumpyrophosphate, 1mg/ml, leupeptin, 1mg/ml, aprotinin and 1mMAEBSF) or
NP-40 lysis buffer (75 mM HEPES pH 7.5, 150mM KCl, 1.5 mM EGTA, 1.5 mM MgCl2, 10% Glycerol, 0.075% NP-40 and the same
protease and phosphatase inhibitor cocktail used in the RIPA buffer). For at least 30min, cells were lysed on an orbital shaker at 4C
and lysates were centrifuged at 20000xg for 10min at 4C. The supernatant was collected and quantified using the BCA assay
(Thermo Scientific) for all experiments. Equalized protein lysates were used for all experiments. Immunoprecipitations were per-
formed with anti-MYC antibodies bound to agarose beads overnight. Beads were washed 3 times with lysis buffer and 1 time
with the corresponding buffer supplemented with extra 150 mM NaCl or KCl.
In vitro kinase assays
HEK293T cells were transfected as described above and treated with nocodazole to synchronize cells in mitosis. The immunopre-
cipitates were given 1 final wash with Kinase Reaction Buffer (KRB: 50 mM Tris pH 7.4, 10 mMMgCl2, 1 mM DTT, 100 mM Sodium-
orthovanadate, 10 mM Sodium Fluoride), and then incubated with KRB supplemented with 200 mM unlabeled ATP, 5 mCi ATP (32P)
and MBP (1-2 mg) substrate at 30C for 30 min with agitation. The addition of SDS–PAGE sample buffer stopped the reaction. Sam-
ples were heated for 5 min at 95C, and resolved by SDS-PAGE for protein separation. The acrylamide gel was then stained with
Coomassie Brilliant Blue, destained to remove background, then dried on Whatman paper prior to visualization by autoradiography.
Protein production and biochemistry
pGEX-6P3-Hec1 CH domain plasmid was transformed into BL21 competent cells and selected on an ampicillin-treated LB plate.
One colony was picked and was seeded in a 10ml tube of LB-ampicillin, overnight at 37C and 250 rpm. From this pre-culture, a
200ml culture was started at 37C and 250 rpm until an O.D value of 0.7-0.9. Synthesis of the recombinant protein was started by
adding 0.5 mM of IPTG (MP biomedical) for 5h at 30C and 250 rpm. Bacteria were then centrifuged at 7700xg for 10min at 4C
and washed one time with PBS 1X and frozen. The next day, the pellet was then lysed in Lysis buffer II ([35] 25 mM Tris,
100 mM NaCl, 5% glycerol,1mM b-Mercaptoethanol, 0.1% Triton X-100, 20 mM b-glycerophosphate, 10 mM Na-pyrophosphate,
100 mMNa-Vanadate, 1mg/ml leupeptin, 1mg/ml aprotinin, 1mM AEBSF, pH8). After sonication (3 rounds of 30 s each at 10% ampli-
tude, waiting for 0.5 s between pulses and 1min on ice between rounds) and 30min incubation on ice, the lysate was centrifuged for
10min at 4C and 13000 rpm. The supernatant was incubated on an orbital shaker for 2h at 4C with glutathione/Sepharose beads
and then washed 2 times with lysis buffer, 1 time with TBS 1X and 1 time with GTB buffer (80 mM PIPES pH7, 2 mMMgCl2, 0.5 mM
EGTA). Glycerol was added to 50% (v:v) and the beads were frozen. Mps1 N and C-terminal fragments were purified from BL21(DE3)
cells as hexahistidine fusions by standard nickel affinity chromatography. To obtain active Mps1, baculovirus-infected Sf9 cells
were lysed by sonication in insect cell breakage buffer (100 mM Tris, pH 7.5, 20% sucrose, 4 mM EDTA, and 0.01% NP-40).
GST-Mps1 was retrieved on glutathione-agarose beads (GE Healthcare), washed extensively with wash buffer (100 mMe3 Current Biology 28, 872–883.e1–e5, March 19, 2018
Tris, pH 7.5, 20% sucrose, 4 mM EDTA, 500 mM KCl), and eluted in K buffer (20 mM potassium phosphate, pH 7.5, 10% glycerol,
0.5 mM EDTA, 0.5% NP-40, 25 mM glutathione, and 2 mM DTT). Eluted material was stored in single-use aliquots at80C. Analyt-
ical size exclusion chromatography was performed on a Superdex 200 column with 50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA,
1 mM DTT as the mobile phase. For velocity sedimentation, samples were loaded onto a 5%–20% glycerol gradient (in 25 mM
Tris, pH 7.5, 0.01% NP-40, and 400 mM NaCl) and centrifuged at 250,000xg for 24 hours at 4C. Limited proteolysis was performed
at 30C while samples were mixed at 300 rpm with 15 mg of Mps1(1-301) and diluted trypsin for 160 minutes. Reactions were termi-
nated with SDS-PAGE sample buffer and analyzed by SDS-PAGE, Coomassie Brilliant Blue staining and mass spectrometry.
Protein-binding assays
For Hec1 CH domain pull-down assays, empty beads or beads bound to GST-Hec1 CH domain were incubated for 1h with end-on
mixing inGTBbuffer containing 5%glycerol and 1mg/ml of BSA. Beadswerewashed once and recombinantMps1 protein fragments
were added to the beads in GTB buffer supplemented with 5%glycerol, 1mg/ml of BSA and 250mMNaCl. Themix was incubated for
a minimum of 2h or overnight on an orbital shaker at 4C. After binding, beads were washed 4 times with the supplemented GTB
buffer. SDS-PAGE sample buffer was added and samples were heated to 95C for 5min amd proteins were visualized by western
blotting.
Cross-linking
To find the optimal ratio of protein: cross-linker, 1 mg of Mps1 WT and 1 mg of Mps1 KD at 0.1 mg/ml in 50 mM HEPES pH7.5,
250mMKCl, 0.05%NP-40, 1mMDTTwere incubated with a 0-, 1-, 10-, 25-, 60-fold weight excess of BS3 for 2h on ice. The reaction
was quenched by addition of ammonium bicarbonate to 50 mM. The cross-linked proteins were analyzed by SDS-PAGE and
NATIVE-PAGE.
For cross-linked peptides identification, 100 mg of Mps1WT and 100 mg of Mps1 KDwere cross-linked at 10:1 protein:BS3 ratio for
2h on ice and the reaction was quenched by addition of ammonium bicarbonate to 50mM. Proteins were separated in NATIVE-PAGE
and stained with Coomassie blue.
Sample preparation for mass spectrometry
Bands containing the cross-linked Mps1 dimers were excised from gel and in-gel digested following standard protocols. The cross-
linked peptides were extracted from gel slices, acidified to pH 3.0 with 0.5% acetic acid and fractionated using the SCX-StageTip.
High salt fractions were diluted four-fold with 0.1% TFA and desalted using C18-StageTips before MS analysis [57].
Mass spectrometry
Cross-linked peptides were analyzed on LTQ-Orbitrap Velos (Thermo Scientific) on a 180 min gradient, using CID collision energy at
35% and fragmenting the eight most intense peptide precursor ions with charge stages z = 3 or higher, per cycle. MS spectra were
recorded at 100000 resolution, and MS/MS spectra at 7500 resolution, both in the Orbitrap.
Database searching
The MS/MS spectra peak lists were generated from the raw data files using the Quant module of MaxQuant v. 1.0.11.2 at default
parameters, except for choosing 200 as ‘top MS/MS peaks per 100 Da’. Cross-linked peptide spectra were searched using the
software package Xi (ERI, Edinburgh) against Mps1 sequence uploaded from SwissProt. Search parameters: MS tolerance
6 ppm, MS/MS tolerance 20 ppm, fixed modification carbamidomethyl on cysteine, variable modifications: oxidation (Met), DST/
BS3-OH (Lys), DST/BS3-NH2 (Lys), the ‘Max. missed cleavages’ was set to 4. Matched spectra and cross-linked peptide candidates
were returned by Xi in pairs. The highest scored matched spectra were validated manually, and to each spectral match a confidence
was allocated. A high-confidence match indicates that for the longer peptide almost all, and for shorter peptides a minimum of three
fragments were matched and all major peaks in the spectrum were accounted for. A low-confidence match indicates that one pep-
tide matched essentially all observed fragments and a second peptide had up to three fragments matched with most of the peaks in
spectrum explained. Reverse peptide sequences were used as a decoy search. All matches had to be highest ranking and unam-
biguous in the target and decoy search.
Immunofluorescence
Cells were grown on coverslips and arrested in mitosis either by nocodazole (330 nM) or by 10–12h release from thymidine block.
For experiments with HeLa Flip-in T-rex cells expressing Mps1 stably, cells were grown on coverslips coated with a solution of
PEI 25 mg/ml and 150 mM NaCl. Cells were fixed in PTEMF buffer (0.2% Triton X-100, 20 mM PIPES pH 6.8, 1 mM MgCl2,
10mMEGTA and 4% formaldehyde) for 10min or anMps1-specific fixation (5min incubation with 1% formaldehyde in PBS, followed
by 0.1 M glycine treatment as a quencher for 1h and 0.1% Triton X-100 for 3min to permeabilize cells) when visualizing Mps1. Before
starting immunofluorescence, coverslips were incubated for at least 30 min with 3%BSA in PBS-T 0.2%. Coverslips were incubated
with primary and secondary antibodies for 2h and 1h respectively at room temperature, except for Mps1 pT686, pSKA3, and Knl1
pT875 (pMELT), which were incubated at 4C overnight in humidified chambers.
Antibodies were used at 1 mg/ml, unless otherwise indicated, as follows: anti-MYC (9E10, Thermo Scientific), anti Knl1 pT875
(1:2000, gift from Dr Yoshinori Watanabe, University of Tokyo), anti-Mps1 (1mg/ml for WB and 5 mg/ml for IF, Sigma), RabbitCurrent Biology 28, 872–883.e1–e5, March 19, 2018 e4
polyclonal phosphospecific antibodies against Mps1 T686, T676 and S821 [11], Rabbit polyclonal phosphospecific antibody
against Mps1 T33 (1:500) was generated against phosphopeptide CKNEDL(pT)DELS, anti Mad2 (4mg/ml [50],) anti-GFP (1:500,
Roche), anti-a-tubulin (DM1A, Santa Cruz Biotechnology), CENP-C (1:1000, MBL International), CREST anti-centromere serum
(1:1000, ImmunoVision), andHoechst 33342 (1mg/ml, Sigma). An antibody specific forMps1’s C terminus (Santa Cruz Biotechnology;
sc-540) was used for Mps1 immunoprecipitations. Hexahistidine-fragments were detected using horseradish peroxidase-
conjugated anti-histidine tag monoclonal antibody (Thermo Fisher). Dylight series secondary antibodies (Thermo Fisher) or (Jackson
ImmunoResearch) were used for immunofluorescence (1:1000) and horseradish peroxidase-coupled secondary antibodies (Jackson
ImmunoResearch) were used for western blotting (1:10000).
Microscopy and live cell imaging
All images were acquired by confocal microscopy on an inverted Olympus IX80 microscope equipped with a WaveFX-Borealin-SC
Yokogawa spinning disc (Quorum Technologies) and an Orca Flash4.0 camera (Hamamatsu). Metamorph software (Molecular De-
vices) was used to perform image acquisition. Optical sections were acquired with identical exposure times for each channel within
an experiment and then projected into a single picture using ImageJ (http://rsb.info.nih.gov). For image processing ImageJ or Photo-
shop were used and all images shown in the same figure have been identically scaled. Live cell imaging was performed on the above
indicated microscopy system that is also equipped with a motorized stage (ASI) and an incubator with atmospheric CO2 heated to
37C. Mps1 stable cell lines were subjected to depletion of endogenous Mps1 for 72 hours, then synchronized in mitosis after a
further 16h block with thymidine. Image acquisition was started 7h after release at 4min intervals. Only cells visibly expressing the
GFP-tagged Mps1 were included in subsequent analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Unless otherwise stated, all experiments were performed in triplicate. Image quantification was realized using ImageJ. For measure-
ment of signal intensities at kinetochores, the CREST, CENP-C or MYC signal were used to generate a binary mask to include kinet-
ochore and centromere signals. Integrated signal intensity was measured in all relevant channels and intensities indicated are values
relative to CREST, CENP-C or MYC, unless otherwise stated. A minimum of ten cells was quantified per condition for all experiments
involving kinetochore quantification. All statistical analysis was performed with Sigmaplot. Data are expressed asmeans ± SEM. The
data were analyzed by ANOVA (one or two way) with Bonferroni’s multiple comparison tests for determination of the significance
of the differences or as otherwise indicated. Statistical significance was considered with a P value of < 0.05. The symbols * were
used in the different graphics to represent the P value: *p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
All MS cross-links of Mps1-WT and Mps1-KD as supplied in Tables S1 and S2.e5 Current Biology 28, 872–883.e1–e5, March 19, 2018
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 Figure S1: Verification of Mps1 siRNA efficiency, related to Figure 1. 
siRNA GL2 (75nM) or siRNA Mps1-A (25nM)+Mps1-B (50nM) were transfected in 
either HeLa S3 (A) or HeLa T-Rex (B) cell lines for 72h before cells were lysed and 
cleared lysates were blotted for Mps1 (upper panels) and tubulin (lower panels).  (C) 
pMELT signals in HeLa T-Rex cells depleted of endogenous Mps1. Cells were 
synchronized in mitosis after release from thymidine arrest before being fixed and 
immunostained for pMELT (Red) for, MYC1 (Green), CREST (Cyan) and Hoechst 
(Blue). Scale bar = 5µm. The graph shows the quantification of the relative pMELT 
intensity from. **** P < 0.0001.  
  
Figure S2: The NTE contributes to Mps1 mitotic hyperphosphorylation, related to 
Figure 1 
(A) HEK 293T cells were transiently transfected with MYC-Mps1 constructs together 
with siMps1, and enriched in mitosis by nocodazole treatment. Cells were treated as 
indicated with 0.5 µM reversine 30min before harvesting. MYC (top panel) and α-tubulin 
(bottom panel) immunoblotting were performed on equalized lysates. 
 
Figure S3: Increased local concentration and transactivation contribute to Mps1 
activation, related to Figure 2. 
(A) HeLaS3 cells were simultaneously transfected with the indicated constructs and 
siMps1 and fixed 10h after release from a thymidine arrest. Cells were immunostained 
against MYC (Red), CREST (Green), and DNA was visualized by Hoechst (Blue). Scale 
bar = 5µm. (B) RPE-1 cells treated for 16h with 3.3µM nocodazole, 0.2µM taxol or 
DMSO, and then fixed. The graph shows the quantification of the pMELT signal relative 
to total Mps1. **** p< 0.0001. (C) Representative images of cells quantified in (B). Cells 
were immunostained against MYC (Green), pMELT (Red), CENP-C (Cyan) and Hoechst 
(Blue). Scale bar = 5µm. (D) HeLa cells treated for 16h with 3.3µM nocodazole, 0.2µM 
taxol or DMSO, and then fixed. Cells were immunostained against MYC (Green), 
pMELT (Red), CENP-C (Cyan) and DNA was marked by Hoechst (Blue). Scale bar = 
5µm. See Figure 2F for quantification. (E) quantitation of the Mps1 signal versus Cenp-C 
at kinetochores for the data in Figure 2F. 
  
Figure S4. Characterization of the anti-pT33 phosphospecific Mps1 antibody, 
related to Figure 4.  
(A) MYC-Mps1 was immunoprecipitated from nocodazole arrested HEK 293T cells and 
left untreated or was treated with calf-intestinal phosphatase for 60min at 37°C before the 
reaction was stopped with SDS-PAGE sample buffer. Resolved samples were probed 
with pT33 antibodies before stripping and reprobing with MYC. (B) Cells expressing 
MYC-Mps1 -WT and -KD were arrested in mitosis with nocodazole and the MYC-Mps1 
proteins were immunoprecipitated from equalized lysates before being resolved by SDS-
PAGE and immunoblotted with the indicated antibodies.  
 
  
 Figure S5. Relief of Mps1 NTE-mediated autoinhibition does not require significant 
Plk1 activity, related to Figure 4. 
 (A) HEK 293T cells were transfected with the indicated Mps1-WT and -KD constructs. 
Lysates were blotted for T33 and T686 phosphorylation. Reblotting with MYC 
demonstrates equal loading. (B) Expression of Mps1 and Plk1 used in (C) and (D). In 
vitro kinase assay of Mps1 1-210 and Mps1 1-210 Δ40-49 recombinant fragments using 
full length Plk1 (C) and full length Mps1 (D). (E) Quantitation of recombinant Mps1 
fragment phosphorylation from (D). (F) MYC-GFP-Mps1 WT and Δ40-49 expressing 
HeLa cells were treated with nocodazole overnight before addition of MG132 and the 
additional inhibitors as indicated.  Fixed cells were stained with MYC, Mps1 pT686, and 
CREST antisera. Relative quantification of pT686 signals is shown. **p < 0.01. 
 
Figure S6. Characterization of the HeLa T-Rex stable cell lines used in this study, 
related to Figure 6.  
(A) Immunofluorescence of HeLa T-Rex cell lines expressing 3xMYC-GFP-MPS1 
constructs. Cells were stained for MYC (green), CREST (cyan) and DNA was visualized 
with Hoechst (blue). Scale bar=5μM. (B) Graphic representing the percentage of GFP-
positive cells of the indicated cell lines. A minimum of 100 cells was counted per cell 
lines. (C) HeLa-T-Rex cell lines stably expressing the indicated constructs were enriched 
in mitosis by nocodazole treatment before fixation and staining with the indicated 
antibodies.  (D) Quantitation of the relative kinetochore intensity of the Mps1 from the 
HeLa-T-Rex cell lines in (C).  (E) Time (mins) in mitosis (nuclear envelope breakdown 
to anaphase onset) of siGL2 and siMPS1 treated cells, the control of the experiment in 
(Figure 6E). A minimum of 50 expressing cells was counted for each condition. n=2. 
Scale bar = 10µm. **** p < 0.0001. (F) Stills from representative cells of each cell line 
from live-cell experiments in (Figure 6E and Figure S6E). 
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Figure S7. Mps1 NTE and TPR crosslinks mapped onto the Mps1 kinase domain, 
related to Figure 7.  
Unique crosslinks identified between the NTE and the kinase domain of Mps1 (brown) 
and the TPR and the kinase domain of Mps1 (red) are mapped on to the structure of the 
inhibited Mps1 kinase domain (PDB ID: 2ZMC).  The catalytic loop is shown in blue 
whereas the activation loop is in green.  (A) and (B) are rotated by 45º. Mapping the 
kinase domain residues identified in the cross-links with the NTE (and TPR) onto the 
Mps1 kinase structure suggests that the NTE region interacts with the N-terminal lobe 
region that is defined by the residues V539FQVLNEKK547 and Q579QHSDKIIR587 
(numbering according to Mps1 isoform 1, NCBI NP_003309.2). The crystal structure of 
Mps1 kinase domain in its inhibited conformation shows that residues of the 
Q579QHSDKIIR587 region form part of α-helix C and are in close spatial proximity (eg, 5 
Å or less) to the activation and the catalytic loops. The C-terminal lobe region that is 
defined by the residues K625SYWK629 and the more C-terminal region C770CLKR774 both 
interact with the TPR motif. The activation loop (residues 672-680) and the loop between 
helices αF and αEF (residues 700-708) are flexible and disordered. The residues 
K625SYWK629 form part of αE helix and are in close proximity to the catalytic loop 
(particularly the side chain of Tyrosine residue Y627). Because the C770CLKR774 residues 
form part of αH helix, the intramolecular interaction of the TPR motif with the kinase 
domain may affect the local conformation of the activation loop, thus contributing to 
modulate Mps1 catalytic activity. Two positively charged residues, K708 and K710, 
which are mapped onto the loop connecting αF and αEF and in close proximity to the 
P+1 and the activation loops, stabilize the active conformation. 
